Nasonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal and perennial forms, as well as nasal polyps in adults and children.

GNH USA supplies Nasonex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution. Clients benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the supply chain.

Nasonex, a nasal corticosteroid, is indicated for several allergic and inflammatory nasal conditions.

Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea by decreasing inflammatory mediators in the nasal mucosa. Seasonal allergic rhinitis: alleviates symptoms triggered by pollen or outdoor allergens, improving daily comfort during spring and summer. Perennial allergic rhinitis: controls year‑round nasal symptoms caused by indoor allergens such as dust mites, pet dander or molds. Nasal polyps: shrinks polyp size and improves nasal airflow, helping to relieve chronic blockage in adults.

Nasonex may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Throat irritation.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes such as cataracts or glaucoma.

Before using Nasonex, consider the following precautions to ensure safe and effective therapy.

Assess for active infections: avoid use in patients with untreated nasal or sinus infections. Monitor in patients with glaucoma or cataracts: corticosteroids may increase intra‑ocular pressure. Use cautiously in children: growth suppression has been reported with long‑term use. Avoid abrupt discontinuation: tapering may be needed after prolonged therapy. Store at room temperature: keep the spray in the original container, protect from moisture and heat.

Nasonex can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure to mometasone. - Systemic corticosteroids: concurrent use can enhance corticosteroid‑related side effects.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may modestly raise mometasone levels. - Antihistamines: may increase risk of nasal dryness. - Nasal decongestant sprays: combined use can raise local irritation.